TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $75,000 | -91.5% | 2,800 | -84.9% | 0.00% | -100.0% |
| Q4 2021 | $883,000 | -21.9% | 18,551 | +8.8% | 0.00% | -50.0% |
| Q3 2021 | $1,131,000 | -44.5% | 17,051 | -34.8% | 0.00% | -33.3% |
| Q2 2021 | $2,039,000 | -8.9% | 26,161 | +10.6% | 0.00% | -25.0% |
| Q1 2021 | $2,237,000 | -54.7% | 23,661 | -41.5% | 0.00% | -60.0% |
| Q4 2020 | $4,933,000 | +116.9% | 40,477 | +55.4% | 0.01% | +100.0% |
| Q3 2020 | $2,274,000 | +1536.0% | 26,047 | +1104.2% | 0.01% | – |
| Q2 2020 | $139,000 | – | 2,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |